Skip to main content
All blogsEducation

Sublingual Peptides: What Works Under the Tongue

Sublingual absorption is real, but it is ruled by molecular size. Small molecules cross the tissue under your tongue. Most peptides are too large to cross it well, no matter what the label on a bottle of drops claims. Here is the honest version of the story, including which molecules make sense sublingually and when injection is still the right call.

PeRx PeptidesReviewed by Dr. Cory Mellon, MD14 min readPublished
Sublingual absorption is ruled by molecular size. Strips fix dose accuracy; they do not change the physics.
Sublingual absorption is ruled by molecular size. Strips fix dose accuracy; they do not change the physics.

Key Takeaways

  • Sublingual absorption is real pharmacology, but permeability falls steeply as molecules get bigger. Small molecules cross the oral mucosa well. Most peptides do not.
  • The only FDA-approved peptide in a sublingual-style format is desmopressin, and even that small, potent molecule absorbs at well under 1 percent. It works because effective doses are tiny.
  • Smaller molecules such as glutathione (about 307 daltons), GHK-Cu, and NAD+ are far more plausible sublingual candidates than multi-thousand-dalton peptides like TB-500 or semaglutide.
  • Research-vendor peptide drops are unregulated products with no human absorption data behind the route. A dissolvable strip made by a licensed compounding pharmacy fixes dose accuracy and product quality, but no format changes the physics of molecular size.
  • Subcutaneous injection delivers close to 100 percent of the dose and remains the standard route for most peptides. PeRx injectables are available today from $199 per month; PeRx does not currently offer a sublingual strip product.

Quick Facts

What Sublingual Means

Absorption through the thin, blood-rich tissue under the tongue, straight into circulation

The Governing Rule

Permeability drops steeply with molecular size; small molecules cross, large peptides mostly do not

Evidence Status

Thin for most peptides; desmopressin is the main approved precedent, absorbed at under 1 percent

Dissolvable Strips

PeRx evaluated a five-compound strip line (BPC-157, BPC/TB-500, GHK-Cu, Glutathione, NAD+) but is not offering it

Sublingual GLP-1s

Compounded semaglutide and tirzepatide, built and clinically approved, coming soon

Available Today

Injectable peptides prescribed through PeRx, from $199 per month

Search for sublingual peptides and you will find research-chemical vendors selling BPC-157 drops, epitalon troches, and tinctures of nearly every peptide in the catalog, all with the same implicit promise: skip the needle, get the results. The promise is appealing. It is also, for most peptides, not supported by the pharmacology.

This guide takes the question seriously instead of selling past it. Sublingual delivery is a legitimate route with real advantages for the right molecules. The catch is that "the right molecules" is a short list, and most peptides sold as drops online are not on it. Understanding why comes down to one variable: size.

Do Sublingual Peptides Actually Work?

The honest answer is: some can, most do not, and almost none of the products marketed this way have human absorption data behind them. Sublingual delivery works brilliantly for small molecules. Nitroglycerin, at about 227 daltons, has been given under the tongue for chest pain since the 1800s because it crosses the oral mucosa in seconds. Peptides are a different situation. They are chains of amino acids, and even a short chain is many times the size of a typical small-molecule drug.

There is exactly one widely cited success story for a peptide in a dissolve-in-the-mouth format: desmopressin, a 1,069-dalton synthetic hormone analog approved as an oral lyophilisate that melts under the tongue. Pharmacokinetic work on that formulation found absorption well under 1 percent of the dose. Desmopressin gets away with this because it is extraordinarily potent, so a sub-1-percent fraction of a small dose is still clinically meaningful. Most peptides people use for recovery, skin, or metabolic goals do not have that kind of potency margin.

Osterberg O, Savic RM, Karlsson MO, et al. Pharmacokinetics of desmopressin administrated as an oral lyophilisate dosage form in children with primary nocturnal enuresis. J Clin Pharmacol. 2006;46(10):1204-1211. PMID: 16988210 View study

So when a vendor sells sublingual TB-500, a molecule nearly five times the size of desmopressin, with no absorption data at all, the reasonable default is skepticism. The route is not fake. The claims built on top of it usually are. The interesting question is which molecules sit on the workable side of the size line, and that is where the rest of this guide goes.

How Sublingual Absorption Works

The floor of the mouth is one of the most permeable surfaces on the body. The tissue under the tongue is thin, non-keratinized, and sits over a dense bed of blood vessels that drain into the internal jugular vein. Anything absorbed there enters systemic circulation directly, skipping both stomach acid and the liver's first-pass metabolism. That is the entire appeal: a swallowed peptide gets shredded by digestive enzymes built specifically to break peptide bonds, while a sublingually absorbed one arrives intact.

The barrier is what happens between the saliva and those blood vessels. A molecule has to diffuse across layers of epithelial cells, and the mucosa behaves like a filter that gets exponentially harder to pass as molecules grow. Small, reasonably fat-soluble molecules slip through. Peptides are large, water-loving, and often charged, which is close to the worst possible profile for crossing a membrane. Reviews of transmucosal protein delivery are blunt about this: without absorption enhancers or carrier systems, macromolecule permeability across oral mucosa is very low, which is why so much pharmaceutical research money goes into engineering ways around the problem.

Wu J, Roesger S, Jones N, et al. Cell-penetrating peptides for transmucosal delivery of proteins. J Control Release. 2024;366:864-878. PMID: 38272399 View study

The size rule of thumb

Below roughly 500 daltons, passive absorption across the oral mucosa is plausible for many molecules. Between 500 and about 1,500 daltons, it becomes partial and unpredictable. In the multi-thousand-dalton range, where peptides like TB-500, semaglutide, and tirzepatide live, meaningful passive sublingual absorption has never been demonstrated in humans. These are boundaries drawn from membrane permeability research, not guarantees in either direction.

One more practical detail matters. Sublingual absorption is a race against swallowing. Whatever dissolves in saliva and gets swallowed before it crosses the mucosa becomes, functionally, an oral dose, subject to all the digestive destruction the sublingual route was supposed to avoid. Contact time with the tissue is a real variable, which is one reason the delivery format, strip versus liquid, is worth caring about.

Strips vs Drops

Almost every sublingual peptide product on the internet today is a liquid: a tincture bottle from a research-chemical vendor, dosed by counting drops under the tongue. These products sit outside the prescription drug system entirely. Nobody verifies what is in the bottle, the actual peptide content can drift far from the label, and a squeeze-and-count dosing method can vary meaningfully from day to day. There are no published human studies showing that any of these drop products deliver their peptide into circulation. The vendors do not claim otherwise in any way that would survive FDA scrutiny, which is why the fine print on these sites reads the way it does.

A dissolvable strip is a different manufacturing answer to the same delivery idea. Each strip is a thin film with a fixed, pre-measured amount of active compound, made to a specification, so dose one and dose thirty are the same dose. Held under the tongue, the film dissolves against the mucosa rather than washing around the mouth in liquid, which helps the contact-time problem. Done properly, a strip line of this kind is manufactured through a licensed US compounding pharmacy, the same regulated pathway as PeRx injectable vials, and prescribed through the same provider review.

What a strip does not do is change the physics. A pharmacy-made strip solves the two problems that are solvable, dose accuracy and product quality. It does not make a 5,000-dalton peptide cross a membrane that stops 5,000-dalton peptides. That is exactly why a credible strip line covers only certain molecules and never a whole catalog, which is the subject of the next section.

Who makes it

Research-Vendor Drops
Unregulated research-chemical vendors
Pharmacy-Made Strips
Licensed US compounding pharmacy

Dose accuracy

Research-Vendor Drops
Counted drops; varies with technique
Pharmacy-Made Strips
Fixed, pre-measured per strip

Identity and potency testing

Research-Vendor Drops
Not required; often absent
Pharmacy-Made Strips
Pharmacy quality standards apply

Prescription and provider review

Research-Vendor Drops
None
Pharmacy-Made Strips
Required

Changes the absorption physics

Research-Vendor Drops
No
Pharmacy-Made Strips
No; size limits still apply

Which Peptides Make Sense Sublingually

Line the popular peptides up by molecular weight and the sublingual question mostly answers itself. Glutathione is a tripeptide of about 307 daltons, one of the smallest molecules in the peptide world. GHK-Cu is a tripeptide-copper complex around 400 daltons. NAD+, which is not a peptide at all but a coenzyme, comes in near 663 daltons. These sit in or near the range where transmucosal absorption is plausible chemistry rather than wishful thinking.

BPC-157 is the middle case: fifteen amino acids, roughly 1,419 daltons. That is large enough that sublingual absorption is genuinely uncertain, and it deserves the honest label of an open question rather than a settled one. BPC-157 does have one unusual property working in its favor: it was derived from a protein found in gastric juice and is unusually stable in the digestive tract, which is why oral BPC-157 capsules exist as a legitimate gut-targeted option. The swallowed fraction of a sublingual dose is not simply wasted the way it would be for a fragile peptide.

Then there is everything else. TB-500 runs near 5,000 daltons. Sermorelin, tesamorelin, CJC-1295, and the other growth hormone secretagogues are all well past the size line, and they also demand dosing precision that an unproven route cannot offer. For these, subcutaneous injection is not one option among several. It is the route with the evidence, and the full injectable catalog reflects that.

This size logic is exactly how PeRx scoped the strip line it evaluated: five compounds, BPC-157, BPC/TB-500, GHK-Cu, Glutathione, and NAD+. Three of the five are small molecules where transmucosal absorption is chemically reasonable, and the BPC options lean on that gastric stability. PeRx ultimately decided not to launch the strips, so nothing sublingual at PeRx is purchasable today. What you can get now are the injectable versions of these same compounds, prescribed through the standard PeRx telehealth flow.

Sublingual GLP-1s: What's Coming

The most requested sublingual products are the ones with the least favorable size math: the GLP-1 class. Semaglutide is about 4,114 daltons and tirzepatide about 4,814. On passive permeability alone, almost none of a sublingual dose should cross the oral mucosa. The reason the route is being explored anyway is that the oral version of this story has already been partially written. FDA-approved oral semaglutide exists, co-formulated with an absorption enhancer, and even with that engineering its bioavailability is on the order of 1 percent. The lesson cuts both ways: getting an incretin peptide through a mucosal surface is possible, and it is hard.

Buckley ST, Baekdal TA, Vegge A, et al. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Sci Transl Med. 2018;10(467):eaar7047. PMID: 30429357 View study

PeRx has built sublingual versions of compounded semaglutide and compounded tirzepatide, and they are coming soon rather than available now. Unlike the strip line, they are formulated as a liquid held under the tongue, the one exception to the strip format. Part of the dose absorbs through the mucosa and the rest is swallowed. Two things should be said plainly. First, these are compounded medications prepared by a licensed pharmacy for individual prescriptions; they are not Ozempic, Wegovy, Mounjaro, or Zepbound, and the clinical trial results behind those approved injectable brands are not evidence about sublingual compounded versions. Second, the evidence base for sublingual delivery of GLP-1s is far thinner than for injection, and PeRx says so on the product pages themselves.

Who is this for, then? People who want GLP-1 therapy and will not use a needle. That is a real population, and for them the practical comparison is not sublingual versus injection, it is sublingual versus nothing. For everyone else, the injectable semaglutide and tirzepatide subscriptions are available now, once weekly, with the substantial evidence base behind the subcutaneous route. If you are weighing the two molecules against each other, the semaglutide vs tirzepatide guide covers that decision, and the compounded semaglutide guide explains what compounded actually means.

Sublingual vs Injection: How to Choose

Subcutaneous injection delivers close to 100 percent of the labeled dose into circulation. No sublingual format will match that, for any peptide, and this guide will not pretend otherwise. If your goal depends on a known systemic dose, growth hormone secretagogue protocols being the clearest example, injection is the answer and the choice is already made. The how to take peptides guide walks through what modern peptide injections actually involve, which is less than most people fear: a ready-to-use vial and an insulin-gauge needle most patients describe as nearly painless.

The case for sublingual is adherence. A protocol you quietly abandon because of needle anxiety delivers exactly 0 percent bioavailability. For needle-averse patients, a pharmacy-made strip of a small, mucosa-plausible molecule is a defensible trade: less certain absorption in exchange for a format they will actually use every day. That trade only makes sense with the small molecules, which is why it is worth being suspicious of anyone selling it for the large ones.

Ideal for

Sublingual makes sense to watch for: needle-averse patients; people interested in the smaller mucosa-plausible molecules (glutathione, GHK-Cu, NAD+); frequent travelers who want dosing with no supplies; patients considering a future sublingual GLP-1 because injection is the barrier to starting at all. At PeRx that today means watching for the sublingual GLP-1s, which remain in development.

Consider alternatives if

Injection remains the right route for: growth hormone secretagogues and any large peptide (TB-500, sermorelin, tesamorelin, CJC-1295/ipamorelin); anyone who wants the route with established bioavailability behind it; GLP-1 therapy today, since the injectables are what is currently available; anyone whose protocol depends on precise systemic dosing.

Every route PeRx offers, injectable vials, oral BPC capsules, and the sublingual line as it launches, runs through the same system: a licensed provider reviews your intake and prescribes an optimal protocol, and a US compounding pharmacy fills it. The route changes. The standard behind it does not.

Sublingual Peptides: Common Questions

It depends almost entirely on molecular size. Small molecules such as glutathione (about 307 daltons) and GHK-Cu can plausibly cross the oral mucosa. Mid-size peptides like BPC-157 are an open question. Large peptides in the multi-thousand-dalton range, including TB-500 and the GLP-1s, have never been shown to absorb meaningfully under the tongue without special formulation. No sublingual peptide product on the consumer market has published human absorption data, so claims of specific bioavailability percentages from vendors should be treated as marketing.

No format matches injection on delivered dose. Subcutaneous injection puts close to 100 percent of the labeled amount into circulation, while sublingual absorption captures a small and usually unmeasured fraction. The practical case for sublingual is not superiority, it is adherence: a route a needle-averse person will actually use beats a route they avoid. For peptides where dosing precision matters, injection remains the standard.

A peptide strip is a thin dissolvable film carrying a fixed, pre-measured amount of a compound, placed under the tongue where it dissolves against the mucosa. Compared with liquid drops, a strip gives exact dosing per unit, longer contact with the absorbing tissue, and, when made by a licensed compounding pharmacy, verified identity and potency. A well-designed strip line sticks to small, stable molecules such as GHK-Cu, glutathione, and NAD+.

No. PeRx evaluated a dissolvable strip line but decided not to offer it, and the sublingual GLP-1s remain in development rather than available, so no sublingual product is currently purchasable from PeRx. The injectable versions of those same compounds, along with the rest of the injectable catalog, are available now through the standard telehealth flow.

Place the strip under the tongue and let it dissolve fully, which takes about a minute, without chewing or swallowing it. Avoid eating, drinking, or smoking for a short window before and after, since food and liquid wash the compound away from the absorbing tissue. The longer the dissolved compound stays in contact with the floor of the mouth, the more of it has a chance to cross before being swallowed.

It becomes an oral dose. Stomach acid and digestive enzymes break most peptides apart before they can be absorbed intact, so for a typical peptide the swallowed fraction contributes little. BPC-157 is the notable partial exception because it is unusually stable in gastric conditions, which is the same reason oral BPC-157 capsules exist as a gut-focused option.

They are unregulated. Research-chemical vendors selling peptide tinctures operate outside the prescription system, with no requirement to verify identity, potency, purity, or sterility, and independent testing of gray-market peptide products has repeatedly found label discrepancies across that industry. Beyond product quality, there is no human evidence that liquid drop formats deliver large peptides across the oral mucosa at all. A low price for a route that does not work is not a bargain.

Desmopressin is the clearest precedent: an approved oral lyophilisate that melts in the mouth, absorbed at well under 1 percent but effective because desmopressin is potent at microgram doses. Oral semaglutide is approved as a swallowed tablet with an absorption enhancer, not a sublingual product. Compounded sublingual peptides, including anything PeRx will offer, are pharmacy-compounded medications prescribed for individual patients and are not FDA-approved products.

There is no evidence that it does, and PeRx will not claim that it does. Ozempic and Wegovy are FDA-approved injectable semaglutide brands whose trial results apply to injection, not to sublingual delivery, and not to compounded preparations. Sublingual GLP-1 delivery has a much thinner evidence base than injection. The sublingual option exists for people who otherwise would not start GLP-1 therapy at all; if a needle is acceptable to you, the injectable route is the one with the data.

The absorbed fraction does. Blood from under the tongue drains toward the heart rather than through the hepatic portal vein, so whatever crosses the mucosa skips first-pass liver metabolism, one of the genuine advantages of the route. The swallowed fraction takes the normal digestive path, liver included. This bypass only matters for the portion that actually absorbs, which brings everything back to molecular size.

Related Guides

Continue reading about peptides and protocols that pair well with this guide.

Ready to get started?

Injectable peptides prescribed by licensed providers and filled by a US compounding pharmacy, available today. Every compound discussed here ships as a ready-to-use injectable vial.

Medical Disclaimer

The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.

The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.

The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.

Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.

Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.

© 2026 Wellness MD Group PC DBA PeRx. All rights reserved.